Clinical trials have shown that semaglutide and liraglutide are generally well tolerated, with gastrointestinal disorders being the most commonly reported AEs, including nausea, diarrhea, vomiting, and constipation, leading to dose reduction or temporary treatment interruption in 12.5% of study participants [40,41,42]
Ready to talk to a licensed healthcare provider about whether a GLP-1 medication fits your health history
This single change fixes more stalls than anything else we see
Given that breastfeeding provides crucial nutritional and immunological benefits to infants, any medication that could potentially compromise infant health or milk supply requires thorough evaluation
Both of these supplements pass the blood-brain barrier which means they can be categorized as nootropics